• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    101.00 Down 0.07(0.07%) Mar 27, 4:00PM EDT
    |After Hours : 100.79 Down 0.21 (0.21%) Mar 27, 7:58PM EDT
    Add to Portfolio
    Prev Close:101.07
    Open:101.02
    Bid:100.78 x 300
    Ask:101.00 x 300
    1y Target Est:119.08
    Beta:0.83
    Earnings Date:Apr 20 - Apr 24 (Est.)
    Day's Range:100.90 - 102.10
    52wk Range:63.50 - 116.83
    Volume:8,815,858
    Avg Vol (3m):13,560,800
    Market Cap:150.43B
    P/E (ttm):13.74
    EPS (ttm):7.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.07%150.43B
    GSKUp 0.77%113.11B
    PFEUp 1.08%211.63B
    RHHBYDown 0.23%N/A

    Key Statistics

    Forward P/E (1 yr):9.83
    P/S (ttm):6.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :9.52
    Quarterly EPS Est (Mar-15) :2.25
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.80

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback